ChinaCureLink3 days ago11 min readBlogMultiple Myeloma in China 2026: Domestic BCMA CAR-T Delivers 64% 12-Month PFS
ChinaCureLink5 days ago8 min readCasesDual-Target CAR-T Cell Therapy for Refractory and Relapsed Burkitt Lymphoma: A Five-Year Survival Case Study in China